
News|Articles|December 1, 2001
Visudyne (Verteporfin for injection) QLT Phototherapeutics/Novartis
New Indication: Light-activated ophthalmic cleared for CNV due to two additional causes
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Immunotherapy combination of teclistamab and daratumumab heralded as potential 'functional cure' for multiple myeloma | ASH 2025
2
The buzz about and the barriers to CAR T-cell therapy | ASH 2025
3
Brainomix 360 e-Lung Technology speeds up PPF detection
4
Semaglutide shows promise in addressing metabolic risk in patients with schizophrenia
5






















































